GR3034708T3 - Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof. - Google Patents

Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.

Info

Publication number
GR3034708T3
GR3034708T3 GR20000402397T GR20000402397T GR3034708T3 GR 3034708 T3 GR3034708 T3 GR 3034708T3 GR 20000402397 T GR20000402397 T GR 20000402397T GR 20000402397 T GR20000402397 T GR 20000402397T GR 3034708 T3 GR3034708 T3 GR 3034708T3
Authority
GR
Greece
Prior art keywords
retrovirus
antigenic
nucleic acid
acid components
type hiv
Prior art date
Application number
GR20000402397T
Other languages
English (en)
Inventor
Luc Montagnier
Solange Chamaret
Denise Guetard
Marc Alizon
Francois Clavel
Mireille Guyader
Pierre Sonigo
Francoise Brun-Vezinet
Marianne Rey
Christine Rouzioux
Christine Katlama
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27576220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3034708(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR8600911A external-priority patent/FR2593190B1/fr
Priority claimed from FR8600910A external-priority patent/FR2593189B1/fr
Priority claimed from FR8601635A external-priority patent/FR2593922B1/fr
Priority claimed from FR8601985A external-priority patent/FR2594229B1/fr
Priority claimed from US06/835,228 external-priority patent/US4839288A/en
Priority claimed from FR8603881A external-priority patent/FR2596063B1/fr
Priority claimed from FR8604215A external-priority patent/FR2597500B1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of GR3034708T3 publication Critical patent/GR3034708T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
GR20000402397T 1986-01-22 2000-10-30 Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof. GR3034708T3 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
FR8600911A FR2593190B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8600910A FR2593189B1 (fr) 1986-01-22 1986-01-22 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601635A FR2593922B1 (fr) 1986-02-06 1986-02-06 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8601985A FR2594229B1 (fr) 1986-02-13 1986-02-13 Nouveau retrovirus du type lav-ii susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US06/835,228 US4839288A (en) 1986-01-22 1986-03-03 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
FR8603881A FR2596063B1 (fr) 1986-03-18 1986-03-18 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
FR8604215A FR2597500B1 (fr) 1986-03-24 1986-03-24 Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida
US91608086A 1986-10-06 1986-10-06
US93318486A 1986-11-21 1986-11-21
EP87400151A EP0239425B1 (fr) 1986-01-22 1987-01-22 Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques

Publications (1)

Publication Number Publication Date
GR3034708T3 true GR3034708T3 (en) 2001-01-31

Family

ID=27576220

Family Applications (3)

Application Number Title Priority Date Filing Date
GR88300056T GR880300056T1 (en) 1986-01-22 1988-05-20 Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
GR89400288T GR3001096T3 (en) 1986-01-22 1989-12-08 Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
GR20000402397T GR3034708T3 (en) 1986-01-22 2000-10-30 Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GR88300056T GR880300056T1 (en) 1986-01-22 1988-05-20 Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
GR89400288T GR3001096T3 (en) 1986-01-22 1989-12-08 Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof

Country Status (15)

Country Link
EP (2) EP0320495B1 (el)
JP (7) JP2611106B2 (el)
AR (1) AR243931A1 (el)
AT (2) ATE195148T1 (el)
AU (1) AU601397B2 (el)
DE (3) DE3752319T2 (el)
DK (2) DK175959B1 (el)
ES (1) ES2150897T3 (el)
GR (3) GR880300056T1 (el)
HK (1) HK62091A (el)
NZ (1) NZ219024A (el)
OA (1) OA08468A (el)
PT (1) PT84182B (el)
SG (1) SG28591G (el)
WO (1) WO1987004459A1 (el)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
DE3856595D1 (de) * 1987-01-16 2009-01-22 Pasteur Institut HIV-2 und SIV-1 Nukleotidsequenzen
ES2104556T3 (es) * 1987-01-16 1997-10-16 Pasteur Institut Peptidos que tienen propiedades inmunologicas de hiv-2.
WO1988007375A1 (en) * 1987-03-23 1988-10-06 Hiver Limited Novel vaccines
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
EP0316695B1 (de) * 1987-11-16 1993-03-31 F. Hoffmann-La Roche Ag Rekombinante HIV-2 Polypeptide
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
EP0327801A1 (en) * 1988-01-08 1989-08-16 Deutsches Primatenzentrum Gesellschaft Mbh HIV-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
US5208321A (en) 1988-06-09 1993-05-04 Institut Pasteur HIV-2 transmembrane glycoprotein homodimer (GP 80)
DE3853422T2 (de) * 1988-06-09 1995-10-26 Innogenetics Nv HIV-3-Retrovirus und seine Verwendung.
US6197496B1 (en) 1988-06-09 2001-03-06 Institut Pasteur Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80
EP0345559A3 (en) * 1988-06-10 1990-07-11 Abbott Laboratories Hiv-2 variants
DE68929467T3 (de) * 1988-06-14 2016-12-22 Qiagen Gmbh HIV-2 Varianten
WO1990013314A2 (fr) * 1989-05-12 1990-11-15 Institut Pasteur Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)
FR2646854A1 (fr) * 1989-05-12 1990-11-16 Pasteur Institut Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique
EP0682951B1 (en) * 1989-05-31 1997-12-17 Institut Pasteur Immunogenic compositions comprising a purified antigen constituted by the envelope glycoprotein of the HIV-2 EHO retrovirus
ES2275451T3 (es) 1989-06-02 2009-02-16 Institut Pasteur Secuencias nucleotidicas procedentes del genoma de los retrovirus del tipo vih-1,vih-2 y siv, y sus aplicaciones especialmente para la amplificacion de los genomas de estos retrovirus y para el diagnostico in vitro de las infecciones debidas a estos virus.
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR2647809B1 (fr) * 1989-06-02 1991-09-20 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE69009066T3 (de) 1990-06-15 2001-07-19 Innogenetics N.V., Gent SIV cpz-ant Retrovirus und seine Anwendungen.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds
JP3277045B2 (ja) * 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Ｈｉｖ−グループのレトロウイルスおよびその使用
DE4233646C2 (de) * 1992-10-06 2003-10-23 Dade Behring Marburg Gmbh Retrovirus aus der HIV-Gruppe und dessen Verwendung
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
FR2767337B1 (fr) 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
JP4202750B2 (ja) 2000-10-23 2008-12-24 ジェン−プローブ・インコーポレーテッド ヒト免疫不全ウイルス２（ｈｉｖ−２）を検出するための組成物および方法
ATE478968T1 (de) 2003-12-19 2010-09-15 Gen Probe Inc Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
JP6721772B1 (ja) 2019-03-26 2020-07-15 斉藤　幹雄 清掃装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
EP0387915B1 (en) * 1984-10-18 1993-03-10 Institut Pasteur F antigens of the human immunodeficiency virus, and their applications
US4600413A (en) * 1984-12-10 1986-07-15 Sundstrand Corporation Centrifugal deaerator and pump
JP3105581B2 (ja) * 1991-07-03 2000-11-06 内橋エステック株式会社 面状温度ヒュ−ズ

Also Published As

Publication number Publication date
JP2931294B2 (ja) 1999-08-09
PT84182B (pt) 1989-09-14
EP0320495A1 (fr) 1989-06-14
AR243931A1 (es) 1993-09-30
WO1987004459A1 (fr) 1987-07-30
JP2874846B2 (ja) 1999-03-24
DK493487D0 (da) 1987-09-21
ATE47725T1 (de) 1989-11-15
JP2611106B2 (ja) 1997-05-21
JPH07233196A (ja) 1995-09-05
JPH06113833A (ja) 1994-04-26
GR3001096T3 (en) 1992-04-17
EP0239425A1 (fr) 1987-09-30
JP2801162B2 (ja) 1998-09-21
DE3760912D1 (en) 1989-12-07
JPH0937778A (ja) 1997-02-10
DK175959B1 (da) 2005-08-29
DK200500170A (da) 2005-02-04
AU601397B2 (en) 1990-09-13
GR880300056T1 (en) 1988-10-18
EP0320495B1 (fr) 2000-08-02
PT84182A (pt) 1987-02-01
JPH08113598A (ja) 1996-05-07
DK493487A (da) 1987-11-17
DE239425T1 (de) 1988-06-30
JP2735521B2 (ja) 1998-04-02
AU6891187A (en) 1987-08-14
JPH0975092A (ja) 1997-03-25
ES2150897T3 (es) 2000-12-16
DE3752319D1 (de) 2000-09-07
DK176253B1 (da) 2007-04-30
ATE195148T1 (de) 2000-08-15
EP0239425B1 (fr) 1989-11-02
JPH08275783A (ja) 1996-10-22
NZ219024A (en) 1990-04-26
HK62091A (en) 1991-08-16
OA08468A (fr) 1988-07-29
JPH1118768A (ja) 1999-01-26
DE3752319T2 (de) 2001-03-15
JP2771519B2 (ja) 1998-07-02
SG28591G (en) 1993-02-19

Similar Documents

Publication Publication Date Title
DE3760912D1 (en) Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
EP0179139A4 (en) ANALYSIS, VACCINE AND IMMUNOGEN OF THE VIRUS ASSOCIATED WITH LEUKEMIA.
PL268266A1 (en) The method of manufacture of proteins env virus aids
FI875073A7 (fi) Upprivningsbar kapsyl.
FI871362A7 (fi) Virusrokote.
FI882173L (fi) Syntetisk peptidantigen foer faststaellande av hiv-2 smitta.
DE3785404D1 (de) Impfstoffe.
NO873080D0 (no) Mikrobicid tilberedning.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
DE3788806D1 (de) Kugelförmige hybrid-hiv-antigene.
NO165683C (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
FI875147A7 (fi) Leipää korjaava valmiste.
DE3786301D1 (de) Kombinierter impfstoff.
DE3789520D1 (de) Ein-Buchstaben Alphabet.
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
EP0266401A4 (en) VACCINE.
ES2014488B3 (es) Procedimiento de preparacion de mercaptoalcoholes.
FI881123L (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
DK388986D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
FI872735L (fi) Nya vacciner.
DE3686396D1 (de) Impfstoff ohne hilfsmittel.
GB2198764B (en) Ring beam.
ES555885A0 (es) Alineador-centrador universal.
NO875465D0 (no) Fremgangsmaate for fremstilling av aminoalkanoyl-dibenzo(d,g)(1,3,6)dioxazociner.
FI884722L (fi) Vattenloesligt universallim.

Legal Events

Date Code Title Description
MA Right expired